Drug
Seromycin
Seromycin is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (50.0%)
Phase 31 (50.0%)
Trials by Status
completed267%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnphase_2
D-Cycloserine and Virtual Reality Exposure Therapy
NCT02933684
completed
The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.
NCT01733030
completedphase_3
Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
NCT00182000
Clinical Trials (3)
Showing 3 of 3 trials
NCT02933684Phase 2
D-Cycloserine and Virtual Reality Exposure Therapy
NCT01733030
The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.
NCT00182000Phase 3
Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3